Yichao Zheng

13PUBLICATIONS
13CO-AUTHORS
Molecular targetsInnate immunityCheminformatics and quantitative structure-activity relationshipsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 29, 2025
Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional Regulation.

Xing-Jie Dai, Leipeng Xue, Ying Liu

|Apr 21, 2025
The Exploration of Indole-Based LSD1-Targeted Inhibitors for Enhanced Immune Response in Gastric Cancer via the PD-L1/PD-1 Axis.

Hang Zhang, Yujie Zhang, Yinping Geng

|Sep 12, 2024
Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer.

Bo Wang, Shu-Wu Wang, Ying Zhou

|Oct 05, 2023
Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer.

Chunlong Zhao, Yu Zhang, Jin'ge Zhang

|Mar 01, 2023
Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells.

Xing-Jie Dai, Li-Juan Zhao, Long-Hua Yang

|Jul 12, 2022
Generation, secretion and degradation of cancer immunotherapy target PD-L1.

Dan-Dan Shen, Ya-Ping Bi, Jing-Ru Pang

Pageof 3

Frequent Collaborators

6 joint publications

Hong-Min Liu

3 joint publications

Xing-Jie Dai

2 joint publications

Bo Wang

1 joint publications

Cheng Zhang